Cardiac amyloidosis
Clinical trials for Cardiac amyloidosis explained in plain language.
Never miss a new study
Get alerted when new Cardiac amyloidosis trials appear
Sign up with your email to follow new studies for Cardiac amyloidosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can AI read fused PET and MRI scans to forecast survival in a rare heart disease?
Diagnosis By invitation onlyResearchers at Beijing Anzhen Hospital are studying whether a computer model that combines two types of heart scans can predict 12-month survival in people with light-chain cardiac amyloidosis, a condition where abnormal proteins stiffen the heart. The study enrolls 49 patients w…
Matched conditions: CARDIAC AMYLOIDOSIS
Sponsor: Beijing Anzhen Hospital • Aim: Diagnosis
Last updated Sep 12, 2026 00:00 UTC
-
Can a new PET tracer light up amyloid in the heart?
Diagnosis By invitation onlyThis trial is testing whether an investigational PET radiotracer called [18F]Fluselenamyl can detect amyloid deposits in the heart. Adults with confirmed or suspected cardiac amyloidosis will receive a single injection of the tracer and undergo PET imaging, along with a cardiac M…
Matched conditions: CARDIAC AMYLOIDOSIS
Phase 1 • Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Aug 20, 2026 00:00 UTC
-
AI eye on the heart: could a computer catch a rare, Often-Missed disease?
Diagnosis By invitation onlyThis trial tests whether an artificial intelligence tool called EchoNet-LVH can help screen for cardiac amyloidosis, a rare but serious heart condition that is often misdiagnosed. The AI analyzes routine echocardiograms to flag suspicious patterns that might indicate the disease.…
Matched conditions: CARDIAC AMYLOIDOSIS
Sponsor: Cedars-Sinai Medical Center • Aim: Diagnosis
Last updated Jul 24, 2026 00:00 UTC
-
Could a common hand condition reveal hidden heart disease? new imaging trial investigates
Diagnosis By invitation onlyThis study tests whether a radioactive tracer called 124I-evuzamitide can detect amyloid deposits in the heart and elsewhere in people aged 60 and older who have lumbar spinal stenosis or carpal tunnel syndrome. Participants will receive a single dose of the tracer and undergo a …
Matched conditions: CARDIAC AMYLOIDOSIS
Phase 2 • Sponsor: University of Tennessee Graduate School of Medicine • Aim: Diagnosis
Last updated Jul 23, 2026 00:00 UTC
-
Simple blood test could catch hidden heart disease in seniors
Diagnosis By invitation onlyThis study is testing a way to find cardiac amyloidosis—a rare but serious heart condition—earlier in people aged 65 and older. Researchers in Turkey will screen 800 patients at family medicine clinics using simple blood tests and medical history. The goal is to see if this appro…
Matched conditions: CARDIAC AMYLOIDOSIS
Sponsor: Kotyora Family Medicine Health Management and Education Association • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
New PET scan could reveal hidden heart scarring in rare disease
Knowledge-focused OngoingThis study tested whether a special PET imaging probe called [68Ga]CBP8 can measure scarring (fibrosis) in the hearts of people with cardiac amyloidosis, a rare condition where abnormal proteins build up in the heart. Researchers compared 18 participants with cardiac amyloidosis …
Matched conditions: CARDIAC AMYLOIDOSIS
Phase 3 • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC